PUBLISHER: The Business Research Company | PRODUCT CODE: 1827672
PUBLISHER: The Business Research Company | PRODUCT CODE: 1827672
Nephrology and urology devices play a crucial role in the diagnosis and treatment of kidney and genitourinary diseases.
The primary categories of nephrology and urology devices encompass dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, as well as endoscopy devices and equipment. Dialysis devices and equipment are instrumental in the dialysis process, functioning as artificial kidneys to filter a patient's blood, eliminating excess water and waste products when kidney function is impaired. Expenditure for these devices can be both public and private. These devices and equipment utilize instruments/equipment and disposables, serving a wide range of end-users including hospitals and clinics, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The nephrology and urology devices market research report is one of a series of new reports from The Business Research Company that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nephrology and urology devices market size has grown strongly in recent years. It will grow from $55.22 billion in 2024 to $58.39 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to aging population, high prevalence of urological disorders, chronic kidney disease (ckd) management, healthcare reimbursement.
The nephrology and urology devices market size is expected to see strong growth in the next few years. It will grow to $74.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to telemedicine and remote consultations, personalized medicine, value-based care, emerging markets growth, artificial intelligence (AI) integration. Major trends in the forecast period include minimally invasive procedures, remote monitoring and telehealth, 3D printing of urological implants, smart catheters and drainage devices, home dialysis solutions.
The forecast of 6.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on dialysis-grade polymer membranes from Germany, raising expenses for hemodialysis filters and urinary stents, potentially impacting kidney disease treatment accessibility.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of kidney and urinary tract diseases is set to drive the growth of the nephrology and urology devices market in the future. These health issues affect various components of the urinary system, including the kidneys, ureters, bladder, and urethra. Medical devices in the field of nephrology and urology play a crucial role in addressing conditions like chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, in June 2023, Kidney Research UK reported that over 7.19 million people in the UK were affected by chronic kidney disease, which accounts for more than 10% of the UK's population. The number is projected to increase to 7.61 million people by 2033. Consequently, the rising incidence of kidney and urinary tract diseases is expected to be a significant driver of growth in the nephrology and urology devices market.
The increase in the patient population, driven by the growing global elderly demographic, has significantly contributed to the historical growth of the nephrology and urology devices market. For instance, in January 2024, the Population Reference Bureau (PRB), a US-based non-profit organization, reported that the number of Americans aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, the proportion of this age group within the total population is expected to rise from 17% to 23%. With the U.S. population now at its oldest in history, the growing geriatric demographic is driving increased demand for medical care and contributing to higher healthcare expenditures.
Leading companies in the nephrology and urology devices market are leveraging advanced technologies, such as artificial intelligence (AI), to improve diagnostic accuracy and expand treatment options for patients. AI tools, which encompass software applications and systems utilizing machine learning algorithms, data analytics, and other advanced computational techniques, are designed to enhance healthcare outcomes. For example, in April 2024, Dornier MedTech GmbH, a Germany-based medical device company, launched UroGPT. This AI-powered tool, designed specifically for kidney stone patients, uses natural language processing to provide real-time, personalized support. Acting as a chatbot, UroGPT interprets patient queries about kidney stones and delivers tailored, easy-to-understand responses, addressing patients' concerns and anxieties effectively.
Major companies in the nephrology and urology markets are actively investing in research and development of advanced technologies to expand their product portfolios and enhance their market share. One such advancement is the development of ambulatory peritoneal dialysis machines, which provide patients with the flexibility to perform dialysis at home or while on the move. This innovation offers convenience and mobility to patients in managing their condition. In June 2023, LiberDi Ltd., an Israeli medical device company, gained FDA approval for a continuous ambulatory peritoneal dialysis machine. This system is designed to offer patients ease of use, mobility, automatic catheter connection flush technology, and continuous monitoring, allowing them to conveniently carry out their daily dialysis routines at home or in various settings.
Major companies operating in the nephrology and urology devices market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc., Boston Scientific Corporation, Coloplast Private Limited, Convatec Group PLC, Hollister Incorporated, Teleflex Incorporated, J and M Urinary Catheters LLC, NxStage Medical Inc., Olympus Corporation, Stryker Corporation, Karl Storz Se & Co. KG, Richard Wolf GmbH, Becton, Dickinson and Company, Terumo Corporation, Uromed Kurt Drews KG, Urocare Products Inc., Urotech GmbH, Wellspect Healthcare AB, Medtronic PLC, Dornier MedTech GmbH, Nikkiso Co. Ltd., Siemens Healthineers AG, Nipro Corporation, Urologix LLC, Johnson & Johnson, Abbott Laboratories.
North America was the largest region in the global nephrology and urology devices market in 2024. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the nephrology and urology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa
The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nephrology And Urology Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nephrology and urology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for nephrology and urology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nephrology and urology devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.